Having trouble viewing this email? View in your browser.
ESCMID Logo

6 December 2016
WEEKLY NEWS

Dear colleagues,

The ESCMID Study Group for Antibiotic Policies (ESGAP) and the ESCMID Study Group for Bloodstream Infections and Sepsis (ESGBIS) are launching the ESGAP/ESGBIS bloodstream infection survey to explore current practices regarding the management of bacteraemia/candidaemia. To read more about it, check out ESGAP’s website and click here to participate.

Please also support two surveys that are being conducted by colleagues at affiliated research institutes:

  • The Institute of Tropical Medicine in Antwerp is asking microbiologists, medical doctors, pharmacists and nurses at hospitals in low- or middle-income countries to take part in a survey on antibiotic stewardship.
  • The Infectious Diseases Research Group at the Institute of Biomedicine of Seville (IBiS) is conducting a survey to find out how you use multiplex PCR panels for the identification of viruses as etiologic agents of community-acquired pneumonia in daily clinical practice.

Best regards, your ESCMID communications editors

 

Abstract submission for ECCMID 2017 is now closed

We thank you for your abstract submissions for ECCMID 2017. Our reviewers will start today to assess the almost 5,000 abstracts we have received for our congress in Vienna. Submitters will be notified about acceptance before the early-bird registration deadline: 26 January 2017.

› Read more
 

EUCAST publishes landmark paper on role of WGS in AST

The European Committee on Antimicrobial Susceptibility Testing (EUCAST) reviewed the use of whole-genome sequencing (WGS) for antimicrobial susceptibility testing (AST). The EUCAST experts concluded that for most bacterial species there is currently insufficient evidence to support the use of WGS-inferred AST to guide clinical decision making. They state that WGS-AST should be a funding priority if it is to become a rival to phenotypic AST. The major limitations to widespread adoption for WGS-based AST in clinical labs remain the current high-cost and limited speed of inferring antimicrobial susceptibility from WGS data as well as the dependency on prior culture since analysis directly on specimens remains challenging.

› Read more
 

CMI highlight: efficacy, safety of withholding antimicrobials in children with fever and neutropenia

Researchers in Chile studied the efficacy and safety of withholding antimicrobials in children with cancer, fever and neutropenia (FN) with a demonstrated respiratory viral infection. The authors conclude that it is safe to reduce antimicrobial treatment in children with FN and respiratory viral infections. Physicians should favour the adoption of evidence-based management strategies, based on clinical and microbiological/molecular diagnostic criteria.

› Read more
 

Congress on tropical medicine, microbiology, parasitology, HIV in Cuba

The 9th Cuban Congress of Microbiology and Parasitology, the 6th National Congress of Tropical Medicine and the International Symposium on HIV Infection in Cuba will be held from 5 to 8 December 2017 at the Institute of Tropical Medicine Pedro Kourí  in Havana, Cuba. The event marks the 80th anniversary of the Institute of Tropical Medicine Pedro Kourí (IPK), one of the most celebrated in Latin America. ESCMID supports science in Cuba and is collaborating with infectious disease and clinical microbiology institutions to organize future activities. Read more about the congress in the first announcement.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.